FISK4: A Study of the Effects of Intake of Two Cod Residual Meals on Glucose Regulation in Overweight and Obese Adults

Sponsor
University of Bergen (Other)
Overall Status
Completed
CT.gov ID
NCT01894542
Collaborator
Granit AS Transport & Tourism (Other), Norwegian Seafood Center (Other), Nofima (Other)
55
1
3
76
0.7

Study Details

Study Description

Brief Summary

The investigators have previously shown the intact protein from cod filet improves glucose regulation and serum lipid profile in overweight adults. A large amount of trimmings from various fish species such as cod is thrown away or sold at very low prices for animal feed, and analyses of the amino acid composition reveals that this can be a good protein source for humans. Two fractions are normally isolated from intact fish meal, i.e. water soluble and non-water soluble proteins. In the present study the investigators will compare these fractions, by studying their effects on glucose regulation in overweight/obese adults.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Cod protein from presscake
  • Dietary Supplement: Cod protein from presscake + stickwater
  • Dietary Supplement: Control
N/A

Detailed Description

Participants receive 6g per day of water soluble on non-water soluble cod protein as tablets for 8 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
55 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
An 8 Week Study to Compare the Effects of Two Combinations of Water Soluble and Non-water Soluble Cod Residual Meals on Glucose Regulation in Overweight and Obese Adults
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Dec 1, 2014
Actual Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cod protein from presscake

Dietary Supplement: Cod protein from presscake
6g protein per day for 8wk

Experimental: Cod protein from presscake + stickwater

Dietary Supplement: Cod protein from presscake + stickwater
6 g protein per day for 8 wk

Placebo Comparator: Control

Control group will receive tablet containing only tablet fillers (the same as in the cod protein tablets).

Dietary Supplement: Control

Outcome Measures

Primary Outcome Measures

  1. Glucose tolerance [8 weeks]

    Serum glucose will be measured in fasting and postprandial state

Secondary Outcome Measures

  1. Gene expression [8 weeks]

    Changes in gene expression in adipose tissue related to the circulating markers of glucose regulation.

  2. Amino acids and amino acid metabolites [8 weeks]

    Amino acids and amino acid metabolites will be measured in serum and urine

  3. Comparisons of metabolites and co-factors involved in one-carbon metabolism in serum and urine [8 weeks]

    Concentrations of relevant metabolites and co-factors were measured in serum and urine

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI>28

  • healthy

  • fasting blood glucose <7.0 mmol/L

  • stable body weight with less than 5 kg fluctuation during the last 4 months

Exclusion Criteria:
  • known disease or metabolic disturbances related to overweight or obesity

  • use of prescription medications that affect blood glucose, blood lipids or inflammatory status

  • allergies towards fish or seafood

  • undertaking a weight loss diet

  • tobacco use exceeding >15 cigarettes/day

  • pregnancy or breastfeeding

  • high seafood consumption

  • use of dietary supplements including cod liver oil or other marine fatty acids

  • allergies towards fish, milk, egg

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Bergen Bergen Norway

Sponsors and Collaborators

  • University of Bergen
  • Granit AS Transport & Tourism
  • Norwegian Seafood Center
  • Nofima

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Oddrun Anita Gudbrandsen, PhD, University of Bergen
ClinicalTrials.gov Identifier:
NCT01894542
Other Study ID Numbers:
  • 2011/572-14
First Posted:
Jul 10, 2013
Last Update Posted:
Apr 7, 2022
Last Verified:
Mar 1, 2022
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2022